Tinda, Jerwin D.
HRN: 28-23-67 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2025
CEFTRIAXONE 1G (VIAL)
12/10/2025
12/17/2025
IV
2g
OD
Fracture Left Femur
Checking Final Appropriateness